Six years lat­er, SEC drops claims of ac­count­ing fraud against biotech ex­ec

The US Se­cu­ri­ties and Ex­change Com­mis­sion has dropped its claims against the for­mer CEO of Osiris Ther­a­peu­tics, who was ac­cused of ly­ing about the re­gen­er­a­tive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER